1.373 articles found

Plasma Synuclein Aggregate Detection via Constant Shake‐Induced Conversion: A Novel Biomarker for Parkinson's Disease Diagnosis and Progression

Ryoo N, Ko H.

Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025-12-01

Gray and white matter pathology progression in Parkinson's disease patients that develop mild cognitive impairment

Moqadam R, Azizi H, Zeighami Y, Dadar M.

Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025-12-01

Author Correction: A blood-based DNA damage signature in patients with Parkinson's disease is associated with disease progression.

Sproviero D, Payán-Gómez C, Milanese C, Barnhoorn S, Sun S, Gyenis A, Delia D, Lashley T, Hoeijmakers JHJ, Vijg J, Mastroberardino PG.

Nat Aging · 2025-12-01

DOI: 10.1038/s43587-025-01037-3PMID: 41258491

Alpinetin Targets Mitophagy Pathways to Mitigate Parkinson's Disease Progression.

Shen Z, Shan X, Zhang S, Huang D, Hu H, Liang Y, Zhu H, Zhang L, Chen Y.

CNS Neurosci Ther · 2025-12-01

DOI: 10.1002/cns.70676PMID: 41331739

PDualNet: a deep learning framework for joint prediction of Parkinson's disease progression subtype and MDS-UPDRS scores.

Rizou V, Grammalidis N, Daras P, Dimitropoulos K.

Sci Rep · 2025-11-25

DOI: 10.1038/s41598-025-25812-9PMID: 41290857

Sex similarities and differences in cognition: A longitudinal study of healthy control participants from the Parkinson Progression Markers Initiative.

Ohlhauser L, Kwan H, Casey H, MacDonald S, Gawryluk JR.

PLoS One · 2025-11-24

DOI: 10.1371/journal.pone.0334358PMID: 41284664

Early deep brain stimulation attenuates parkinsonism progression in a neurotoxin-induced Parkinson's disease mouse model.

Merino-Ruiz MC, Goulart JT, Penha GDS, de Santana IA, Mortari MR.

Exp Neurol · 2025-11-22

DOI: 10.1016/j.expneurol.2025.115567PMID: 41285281

Therapeutic potential of K<sub>ATP</sub> channels in the attenuation of Parkinson's disease pathogenesis and progression - A review.

Gundi B, Ho HL, Zhang X, He A, Xin D, Ferreira AFF, Britto LR, Feng ZP, Sun HS.

Neurochem Int · 2025-11-21

DOI: 10.1016/j.neuint.2025.106091PMID: 41275920

Cross-modal fusion of brain imaging and clinical data for Parkinson's disease progression prediction.

Wen J, Chen A, Liu J, Xiong H, Fang M, Wei X.

PLoS One · 2025-11-20

DOI: 10.1371/journal.pone.0333822PMID: 41264649

Fear of progression in Parkinson's disease: Role of age and occupational status.

D'Souza S, Tekampe E, Falkenburger B, Schnalke N.

J Parkinsons Dis · 2025-11-18

DOI: 10.1177/1877718x251365243PMID: 41252262

Cortical thinning predicts cognitive impairment and progression in Parkinson's disease: The mediating role of p-Tau.

Ren J, Xie D, Wu Z, Xie H, Wang L, Chen F, Xu J, Jin Q, Huang H, Luo Y, Zhu B, Luo M, Chen G, Yang D.

Behav Brain Res · 2025-11-17

DOI: 10.1016/j.bbr.2025.115937PMID: 41237972

Role of the PSMC1 gene in the pathological progression of Parkinson's disease.

Wang Y, Li Y, Chen Z, Zhao Y.

Am J Transl Res · 2025-11-15

DOI: 10.62347/bwyd6434PMID: 41415092